OverviewChartNewsTraderScreen

BNP Paribas Aktienanleihe SNW 26..../  DE000PC7FQT8  /

Frankfurt Zert./BNP
28/05/2024  19:20:18 Chg.-0.330 Bid19:40:27 Ask19:40:27 Underlying Strike price Expiration date Option type
99.140EUR -0.33% 98.860
Bid Size: 20,000		 98.960
Ask Size: 20,000		 SANOFI SA INHABER ... 85.00 EUR 26/09/2024 Call
GlobeNewswire 13:00 NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer
GlobeNewswire 27/05 Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
GlobeNewswire 23/05 CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
GlobeNewswire 21/05 Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
GlobeNewswire 20/05 Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS...
GlobeNewswire 20/05 Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ...
GlobeNewswire 20/05 Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meet...
GlobeNewswire 13/05 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...
GlobeNewswire 13/05 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
TeleTrader 13/05 Europe mixed at open as CPI prints loom
GlobeNewswire 13/05 Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
TeleTrader 10/05 Novavax skyrockets 213.5% in premarket, highest in 16 months
TeleTrader 10/05 Novavax soars 39.6% in premarket after Sanofi license deal
GlobeNewswire 10/05 Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire 09/05 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
TeleTrader 09/05 Europe opens mixed with BoE in focus
GlobeNewswire 08/05 IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 07/05 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 02/05 Regeneron Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 02/05 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 30/04 Press Release: Annual General Meeting of April 30, 2024
TeleTrader 25/04 Europe opens mostly down after corporate earnings
TeleTrader 25/04 Europe down in premarket as financial results pour in
TeleTrader 25/04 Sanofi books net sales of €10.5B in Q1, up 2.4%
GlobeNewswire 25/04 Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance